PT Klinko Karya Imaji Tbk (KLIN.JK)
IDR 172.0
(-3.37%)
IDR 172.0
(-3.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 16.96 Billion | 7.51 Billion | 3.94 Billion | 2.7 Billion |
| Cost of Revenue | 9.61 Billion | 5.05 Billion | 2.7 Billion | 1.92 Billion |
| Gross Profit | 7.34 Billion | 2.46 Billion | 1.24 Billion | 778.11 Million |
| Operating Expenses | 5.51 Billion | 2.87 Billion | 909.99 Million | 633.44 Million |
| Selling, General and Administrative Expenses | 5.37 Billion | 2.87 Billion | 925.29 Million | 585.77 Million |
| Research and Development Expenses | - | - | - | - |
| Other Expenses | - | - | - | - |
| Cost and Expenses | 15.13 Billion | 7.92 Billion | 3.61 Billion | 2.55 Billion |
| Operating Income | 1.96 Billion | -407.02 Million | 328.05 Million | 192.33 Million |
| Interest Expense | - | - | - | - |
| Income Tax Expense | 520.71 Million | 72.27 Million | 45.53 Million | 16.4 Million |
| Earnings before Tax | 991.9 Million | -1.14 Billion | 319.11 Million | 134.29 Million |
| Net Income | 471.19 Million | -1.07 Billion | 273.57 Million | 117.89 Million |
| Earnings Per Share Basic | 0.36 | -0.92 | 5.67 | 2.95 |
| Earnings Per Share Diluted | 0.36 | -0.92 | 5.67 | 2.95 |
| Weighted Average Shares Outstanding | 1.3 Billion | 1.16 Billion | 48.21 Million | 40 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.3 Billion | 1.16 Billion | 48.21 Million | 40 Million |
| Gross Margin | 0.43 | 0.33 | 0.31 | 0.29 |
| EBIT Margin | 0.21 | -0.00 | 0.09 | 0.08 |
| Profit Margin | 0.03 | -0.14 | 0.07 | 0.04 |
| EBITDA | 3.63 Billion | -27.67 Million | 370.44 Million | 223.64 Million |
| Earnings Before Tax Margin | 0.12 | -0.05 | 0.08 | 0.07 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 5.09 Billion | 5.09 Billion | 16.96 Billion | 5.94 Billion | 5.94 Billion | 2.53 Billion |
| Cost of Revenue | 3.21 Billion | 3.21 Billion | 9.61 Billion | 2.78 Billion | 2.78 Billion | 2.02 Billion |
| Gross Profit | 1.88 Billion | 1.88 Billion | 7.34 Billion | 3.15 Billion | 3.15 Billion | 513.37 Million |
| Operating Expenses | 1.45 Billion | 1.45 Billion | 5.51 Billion | 1.63 Billion | 1.63 Billion | 1.12 Billion |
| Selling, General and Administrative Expenses | 1.42 Billion | 1.42 Billion | - | 1.56 Billion | 1.56 Billion | 1.12 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 4.66 Billion | 4.66 Billion | 15.13 Billion | 4.41 Billion | 4.41 Billion | 3.14 Billion |
| Operating Income | 464.89 Million | 464.89 Million | 1.96 Billion | 1.59 Billion | 1.59 Billion | -610.61 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 39.25 Million | 39.25 Million | 520.71 Million | 260.35 Million | 260.35 Million | - |
| Earnings before Tax | 228 Million | 228 Million | 991.9 Million | 1.13 Billion | 1.13 Billion | -635.61 Million |
| Net Income | 188.75 Million | 188.75 Million | 471.19 Million | 871.21 Million | 871.21 Million | -635.61 Million |
| Earnings Per Share Basic | 0.14 | 0.14 | - | 0.67 | 0.67 | -0.48 |
| Earnings Per Share Diluted | 0.14 | 0.14 | - | 0.67 | 0.67 | -0.48 |
| Weighted Average Shares Outstanding | 1.31 Billion | 1.31 Billion | 1.3 Billion | 1.3 Billion | 1.3 Billion | 1.31 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.31 Billion | 1.31 Billion | 1.3 Billion | 1.3 Billion | 1.3 Billion | 1.31 Billion |
| Gross Margin | 0.37 | 0.37 | 0.43 | 0.53 | 0.53 | 0.20 |
| EBIT Margin | 0.15 | 0.15 | - | 0.36 | 0.36 | -0.10 |
| Profit Margin | 0.04 | 0.04 | 0.03 | 0.15 | 0.15 | -0.25 |
| EBITDA | 740.43 Million | 740.43 Million | - | 2.16 Billion | 2.16 Billion | -242.33 Million |
| Earnings Before Tax Margin | 0.09 | 0.09 | 0.12 | 0.27 | 0.27 | -0.24 |
000875
CHCT
SBDS
603075
PXPC
WIX